Immunosuppressant Trough Monitoring

Immunosuppressant trough monitoring maintains therapeutic drug levels preventing organ rejection and toxicity. Target trough concentrations vary by drug and transplant type. Time-dependent concentration changes guide sampling intervals. Inter-individual variability necessitates individualised dosing. Therapeutic drug monitoring enables dose optimisation.

Assay standardisation ensures consistent results across laboratories. Regulatory submissions justify target concentration ranges. Post-transplant progression requires monitoring intensity. Compliance with monitoring enables long-term graft survival. Emerging point-of-care testing expedites results.